miRNA expression in COVID-19.

Roustai Geraylow, Kiarash; Hemmati, Romina; Kadkhoda, Sepideh; Ghafouri-Fard, Soudeh

Roustai Geraylow, Kiarash; Hemmati, Romina; Kadkhoda, Sepideh; Ghafouri-Fard, Soudeh.

Afiliação

Roustai Geraylow K; Student Research Committee, Semnan University of Medical Sciences, Semnan, Iran.
Hemmati R; Student Research Committee, Semnan University of Medical Sciences, Semnan, Iran.
Kadkhoda S; Department of Medical Genetics, Tehran University of Medical Sciences, Tehran, Iran.
Ghafouri-Fard S; Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Gene Rep ; 28: 101641, 2022 Sep.

Article em En | MEDLINE | ID: mdl-35875722

Palavras-chave

ACE2, Angiotensin-converting enzyme 2; ARDS, Acute respiratory distress syndrome; COVID-19; COVID-19, Coronavirus disease 2019; HDAC, Histone deacetylate; HMVEC, Human Lung Microvascular Endothelial Cells; ORF, Open reading frame; ROC, Receiver operating characteristic; SARS-CoV-2; SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2; TLR, Toll-like receptor; TMPRSS2, Transmembrane protease serine 2; UTR, Untranslated region; hBMEC, Human brain microvascular endothelial cells; miRNA; miRNAs, microRNAs

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article